Cervical cancer survivors benefit from psychosocial phone counseling

This article originally appeared here.
Share this content:
Cervical cancer survivors benefit from psychosocial phone counseling
Cervical cancer survivors benefit from psychosocial phone counseling

(HealthDay News) -- A psychosocial telephone counseling (PTC) intervention can be beneficial for cervical cancer survivors, according to a study published online Feb. 23 in the Journal of Clinical Oncology.

Lari Wenzel, Ph.D., from the University of California at Irvine, and colleagues examined the effect of a PTC intervention on quality of life (QOL) in 204 survivors of cervical cancer who were at least nine and less than 30 months from diagnosis. Participants (mean age, 43 years; 40 percent Hispanic, 51 percent non-Hispanic white) were randomized to PTC, which included five weekly sessions and a one-month booster, or usual care (UC).

The researchers found that, compared with UC participants, those receiving PTC had significantly improved depression and improved gynecologic and cancer-specific concerns at four months (all P < 0.05), after adjustment for age and baseline scores. The significant differences in gynecologic and cancer-specific concerns persisted at nine months (P < 0.05). The longitudinal change in overall QOL and anxiety was not statistically significant. Significantly greater improvement in QOL was seen for those with decreasing interleukin (IL)-4, IL-5, IL-10, and IL-13, compared to those with increasing cytokine levels.

"This trial confirms that PTC benefits mood and QOL cancer-specific and gynecologic concerns for a multiethnic underserved population of survivors of cancer," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs